PERSPECTA

News from every angle

Back to headlines

Novo Nordisk Prepares U.S. Launch of Ozempic Pill

Novo Nordisk is reportedly readying the U.S. launch of its Ozempic pill, expanding the availability of the popular diabetes and weight-loss medication in an oral format.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.